Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction
Laura Ajello1, Giuseppe Coppola, Egle Corrado
1Chair and Division of Cardiology, Policlinico Universitario "Paolo Giaccone", Palermo, Italy.
ISRN Cardiology
|April 12, 2013
Insights
Improved survival after heart attacks has led to more cases of left ventricular systolic dysfunction. Early detection and treatment of this condition can improve patient outcomes and reduce healthcare costs.
Area of Science:
- Cardiology
- Heart Failure Research
Background:
- Increased survival rates following acute myocardial infarction (MI) have contributed to a rise in heart failure cases.
- Left ventricular systolic dysfunction (LVSD) is a significant consequence of MI, impacting long-term cardiac function.
Purpose of the Study:
- To highlight the growing prevalence of LVSD post-MI.
- To emphasize the importance of early detection and intervention for asymptomatic LVSD.
- To underscore the potential for improved patient outcomes and reduced healthcare expenditures.
Main Methods:
- Review of epidemiological data on post-MI heart failure.
- Analysis of clinical outcomes associated with early vs. late detection of LVSD.
- Economic evaluation of managing asymptomatic vs. overt heart failure.
Main Results:
- A correlation exists between increased MI survival and a higher incidence of LVSD.
- Early identification of asymptomatic LVSD presents a therapeutic opportunity.
- Timely intervention can mitigate disease progression and associated costs.
Conclusions:
- Addressing asymptomatic LVSD is crucial for managing the increasing burden of heart failure.
- Proactive management strategies can enhance patient prognosis and optimize resource allocation in cardiovascular care.
Abstract:
The increased survival after acute myocardial infarction induced an increase in heart failure with left ventricular systolic dysfunction. Early detection and treatment of asymptomatic left ventricular systolic dysfunction give the chance to improve outcomes and to reduce costs due to the management of patients with overt heart failure.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...